Literature DB >> 12805220

Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD.

A F Baas1, J Boudeau, G P Sapkota, L Smit, R Medema, N A Morrice, D R Alessi, H C Clevers.   

Abstract

The LKB1 gene encodes a serine/threonine kinase mutated in Peutz-Jeghers cancer syndrome. Despite several proposed models for LKB1 function in development and in tumour suppression, the detailed molecular action of LKB1 remains undefined. Here, we report the identification and characterization of an LKB1-specific adaptor protein and substrate, STRAD (STe20 Related ADaptor). STRAD consists of a STE20- like kinase domain, but lacks several residues that are indispensable for intrinsic catalytic activity. Endogenous LKB1 and STRAD form a complex in which STRAD activates LKB1, resulting in phosphorylation of both partners. STRAD determines the subcellular localization of wild-type, but not mutant LKB1, translocating it from nucleus to cytoplasm. One LKB1 mutation previously identified in a Peutz-Jeghers family that does not compromise its kinase activity is shown here to interfere with LKB1 binding to STRAD, and hence with STRAD-dependent regulation. Removal of endogenous STRAD by siRNA abrogates the LKB1-induced G(1) arrest. Our results imply that STRAD plays a key role in regulating the tumour suppressor activities of LKB1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805220      PMCID: PMC162144          DOI: 10.1093/emboj/cdg292

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

1.  The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death.

Authors:  P Karuman; O Gozani; R D Odze; X C Zhou; H Zhu; R Shaw; T P Brien; C D Bozzuto; D Ooi; L C Cantley; J Yuan
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

2.  Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase.

Authors:  A F Wilks; A G Harpur; R R Kurban; S J Ralph; G Zürcher; A Ziemiecki
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

3.  Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways.

Authors:  H Luo; P Rose; D Barber; W P Hanratty; S Lee; T M Roberts; A D D'Andrea; C R Dearolf
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

4.  Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice.

Authors:  Hiroyuki Miyoshi; Masayuki Nakau; Tomo-o Ishikawa; Michael F Seldin; Masanobu Oshima; Makoto M Taketo
Journal:  Cancer Res       Date:  2002-04-15       Impact factor: 12.701

5.  Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1/CIP1).

Authors:  Marianne Tiainen; Kari Vaahtomeri; Antti Ylikorkala; Tomi P Mäkelä
Journal:  Hum Mol Genet       Date:  2002-06-15       Impact factor: 6.150

6.  Identification and characterization of a novel Ste20/germinal center kinase-related kinase, polyploidy-associated protein kinase.

Authors:  Kazuo Nishigaki; Delores Thompson; Takashi Yugawa; Karen Rulli; Charlotte Hanson; Joan Cmarik; J Silvio Gutkind; Hidemi Teramoto; Sandra Ruscetti
Journal:  J Biol Chem       Date:  2003-02-06       Impact factor: 5.157

7.  The human TCF-1 gene encodes a nuclear DNA-binding protein uniquely expressed in normal and neoplastic T-lineage lymphocytes.

Authors:  J Castrop; D van Wichen; M Koomans-Bitter; M van de Wetering; R de Weger; J van Dongen; H Clevers
Journal:  Blood       Date:  1995-10-15       Impact factor: 22.113

8.  Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).

Authors:  P Macchi; A Villa; S Giliani; M G Sacco; A Frattini; F Porta; A G Ugazio; J A Johnston; F Candotti; J J O'Shea
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

9.  Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice.

Authors:  Masayuki Nakau; Hiroyuki Miyoshi; Michael F Seldin; Masayuki Imamura; Masanobu Oshima; Makoto M Taketo
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

10.  The C. elegans par-4 gene encodes a putative serine-threonine kinase required for establishing embryonic asymmetry.

Authors:  J L Watts; D G Morton; J Bestman; K J Kemphues
Journal:  Development       Date:  2000-04       Impact factor: 6.868

View more
  151 in total

1.  Dynamic Lkb1-TORC1 signaling as a possible mechanism for regulating the endoderm-intestine transition.

Authors:  Kathryn E Marshall; Amber J Tomasini; Khadijah Makky; Suresh N Kumar; Alan N Mayer
Journal:  Dev Dyn       Date:  2010-11       Impact factor: 3.780

Review 2.  The role of LKB1 in lung cancer.

Authors:  Montse Sanchez-Cespedes
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

Review 3.  LKB1 signaling in advancing cell differentiation.

Authors:  Lina Udd; Tomi P Mäkelä
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

4.  Cell biology: a cellular choreographer.

Authors:  W James Nelson
Journal:  Nature       Date:  2004-03-04       Impact factor: 49.962

5.  STE20-related kinase adaptor protein α (STRADα) regulates cell polarity and invasion through PAK1 signaling in LKB1-null cells.

Authors:  Carrie M Eggers; Erik R Kline; Diansheng Zhong; Wei Zhou; Adam I Marcus
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

Review 6.  Regulation of gene expression in the intestinal epithelium.

Authors:  Camilla A Richmond; David T Breault
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

7.  Two novel STK11 missense mutations induce phosphorylation of S6K and promote cell proliferation in Peutz-Jeghers syndrome.

Authors:  Ran Li; Zhiqing Wang; Shu Liu; Baoping Wu; Di Zeng; Yali Zhang; Lanbo Gong; Feihong Deng; Haoxuan Zheng; Yadong Wang; Chudi Chen; Junsheng Chen; Bo Jiang
Journal:  Oncol Lett       Date:  2017-11-17       Impact factor: 2.967

8.  MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm.

Authors:  Jérôme Boudeau; Annette F Baas; Maria Deak; Nick A Morrice; Agnieszka Kieloch; Mike Schutkowski; Alan R Prescott; Hans C Clevers; Dario R Alessi
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

Review 9.  Controlling the master-upstream regulation of the tumor suppressor LKB1.

Authors:  Lars Kullmann; Michael P Krahn
Journal:  Oncogene       Date:  2018-03-15       Impact factor: 9.867

10.  The pseudoactive site of ILK is essential for its binding to alpha-Parvin and localization to focal adhesions.

Authors:  Koichi Fukuda; Sudhiranjan Gupta; Ka Chen; Chuanyue Wu; Jun Qin
Journal:  Mol Cell       Date:  2009-12-11       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.